Explore more publications!

The LATAM Ledger: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The LATAM Ledger.

Press releases published on October 24, 2025

The BOW Collective Welcomes Travel Visionary Natajia Miller's Unveiling a New Era Of Barefoot Luxury At 'Embrace Resort'
Red Frog Beach Resort Enters a New Era of Growth and Community
Cabo Emerges as a Top New Year’s Destination: Luxury Villas Nearly Fully Booked
Influur Takes Over Grand Race of Mexico With Exclusive Influencer Suite
WEALTH UNTOLD to Screen at the Gulf and Caribbean Fisheries Institute Conference
Algareplena y Los Chinchillos del Caribe Lanzan Pa’ Los Dolores
Protecting Blue Whales and Blue Skies Becomes State Law in one of the World’s Biggest Economies
SuperX AI Technology Limited Announces $39.9 Million Private Placement Offering with Institutional Investor
Mexico’s Connected Ship Market to Hit USD 2 Billion by 2035, Growing at 6.8% CAGR
Discovery Announces Details of Third Quarter 2025 Conference Call and Webcast
Enzon and Viskase Announce Amendment to Merger Agreement
Arvinas Presents Preclinical Data for ARV-806 Demonstrating Robust and Differentiated Activity in Models of KRAS G12D-mutated Cancer at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
Blazpay Presale Explodes 74.6% as Bitcoin Consolidates Near $108K and Ethereum Dips Below $3,830
TR-1 Notification and Block Listing Return
Tapefly's 'In the Garden': A Swedish Indie Oddity Blossoms in the Age of AI and Harmony
Splendor ($SPLD) Begins Trading on LBank Following Network Launch
Halda Therapeutics Announces First-in-Human Results for HLD-0915, an Oral RIPTAC™ Therapeutic Demonstrating Encouraging Safety and Anti-Tumor Activity in Metastatic Castration-Resistant Prostate Cancer (mCRPC)
Volcan Compañía Minera S.A.A. Announces Early Tender Offer Results for Any and All of its Outstanding 8.750% Senior Secured Notes due 2030 and Consent Solicitation
Aprea Therapeutics Provides Clinical Update from ACESOT-1051 Trial Showing Early Signals of Activity for WEE1 Kinase Inhibitor APR-1051
AlphaTON Capital Appoints Wes Levitt as Chief Financial Officer

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions